Observational Study - ILM Peeling

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2010 by University Hospital Tuebingen.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University Hospital Tuebingen
ClinicalTrials.gov Identifier:
NCT01083056
First received: March 8, 2010
Last updated: March 9, 2010
Last verified: March 2010
  Purpose

This observational study investigates the effects of epimacular membrane peeling on the structure and function of the retina.


Condition
Epimacular Gliosis
Macular Hole

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Study On Retinal Structure And Function Before And After Epimacular Membrane Peeling

Further study details as provided by University Hospital Tuebingen:

Estimated Enrollment: 50
Study Start Date: March 2010
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
Epimacular Gliosis Without Macular Hole
Epimacular Gliosis With Macular Hole

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Inpatients at the University Eye Hospital Tuebingen

Criteria

Inclusion Criteria:

  • Clinical diagnosis of Epimacular Gliosis
  • Must be scheduled for ILM-peeling independently of study
  • Must be older then 18 years of age

Exclusion Criteria:

  • Visual acuity > 0,4 logMAR (< 20/50 EDTRS)
  • Other ophthalmological disorder affecting visual acuity and/or visual field and/or retinal structure
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01083056

Contacts
Contact: M. Dominik Fischer, MD +49 7071 29 ext 83721 Dominik.Fischer@med.uni-tuebingen.de
Contact: Gabriel Willmann, MD +49 7071 29 ext 83721 Gabriel.Willmann@med.uni-tuebingen.de

Locations
Germany
Centre for Ophthalmology, University Hospital Tuebingen Recruiting
Tuebingen, BW, Germany, 72076
Contact: M. Dominik Fischer, MD    +49 7071 29 ext 83721    Dominik.Fischer@med.uni-tuebingen.de   
Principal Investigator: Florian Gekeler, MD         
Sub-Investigator: M. Dominik Fischer, MD         
Sub-Investigator: Gabriel Willmann, MD         
Sub-Investigator: Andreas Schatz, MD         
Sponsors and Collaborators
University Hospital Tuebingen
Investigators
Principal Investigator: Florian Gekeler, MD Centre for Ophthalmology, University Hospital Tuebingen
  More Information

No publications provided

Responsible Party: PD Dr. med. Florian Gekeler, Centre for Ophthalmology, University Eye Hospital & Institute for Ophthalmic Research
ClinicalTrials.gov Identifier: NCT01083056     History of Changes
Other Study ID Numbers: ILM Peeling
Study First Received: March 8, 2010
Last Updated: March 9, 2010
Health Authority: Germany: Ministry of Health

Keywords provided by University Hospital Tuebingen:
retina
gliosis
macula
membrane
ILM

Additional relevant MeSH terms:
Gliosis
Retinal Perforations
Pathologic Processes
Retinal Diseases
Eye Diseases

ClinicalTrials.gov processed this record on April 16, 2014